Published in J Clin Psychiatry on April 01, 1991
Sleep-disordered breathing: in depression and schizophrenia. Psychiatry (Edgmont) (2006) 0.76
Influence of chronic barbiturate administration on sleep apnea after hypersomnia presentation: case study. J Psychiatry Neurosci (2000) 0.75
Delay in the recovery of normal sleep-wake cycle after disruption of the light-dark cycle in mice: a bipolar disorder-prone animal model? Psychiatry Investig (2014) 0.75
Impaired energy homeostasis in C/EBP alpha knockout mice. Science (1995) 5.68
Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. Transfusion (1999) 5.67
One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry (1994) 5.29
Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry (2000) 5.21
Body dysmorphic disorder: 30 cases of imagined ugliness. Am J Psychiatry (1993) 4.57
Clozapine. A novel antipsychotic agent. N Engl J Med (1991) 3.72
Cloning and sequence analysis reveal structural variation among related zein genes in maize. Cell (1982) 3.40
Attitudes toward DSM-IV dissociative disorders diagnoses among board-certified American psychiatrists. Am J Psychiatry (1999) 3.29
Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry (2001) 3.27
Attainment and maintenance of reliability of axis I and II disorders over the course of a longitudinal study. Compr Psychiatry (2001) 3.22
Monocyte-conditioned medium, interleukin-1, and tumor necrosis factor stimulate the acute phase response in human hepatoma cells in vitro. J Cell Biol (1986) 3.20
Psychiatric features of individuals with problematic internet use. J Affect Disord (2000) 3.19
The diagnostic Interview for Personality Disorders: interrater and test-retest reliability. Compr Psychiatry (1988) 3.01
Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study. Acta Psychiatr Scand (2007) 2.89
A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry (2000) 2.88
Axis I comorbidity of borderline personality disorder. Am J Psychiatry (1998) 2.71
Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiatry (1992) 2.70
Reported pathological childhood experiences associated with the development of borderline personality disorder. Am J Psychiatry (1997) 2.67
Standards for informed consent in recovered memory therapy. J Am Acad Psychiatry Law (2001) 2.60
Axis II comorbidity of borderline personality disorder: description of 6-year course and prediction to time-to-remission. Acta Psychiatr Scand (2004) 2.51
The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. J Affect Disord (2001) 2.43
Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry (2001) 2.38
Compulsive buying: a report of 20 cases. J Clin Psychiatry (1994) 2.29
Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry (1999) 2.23
Childhood abuse in first-episode psychosis. Br J Psychiatry (1994) 2.17
A novel augmentation strategy for treating resistant major depression. Am J Psychiatry (2001) 2.05
Lower left temporal lobe MRI volumes in patients with first-episode schizophrenia compared with psychotic patients with first-episode affective disorder and normal subjects. Am J Psychiatry (1998) 2.00
Glycerol-induced hemoglobinuric acute renal failure in the rat. I. Micropuncture study of the development of oliguria. J Clin Invest (1966) 1.92
Pharmacological treatment of kleptomania and bulimia nervosa. J Clin Psychopharmacol (1989) 1.91
A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania. J Clin Psychopharmacol (2001) 1.86
Extent of comorbidity between mental state and personality disorders. J Pers Disord (1997) 1.81
Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial. Arch Gen Psychiatry (2000) 1.81
Early nonresponse to fluoxetine as a predictor of poor 8-week outcome. Am J Psychiatry (1995) 1.73
CSF norepinephrine concentrations in posttraumatic stress disorder. Am J Psychiatry (2001) 1.71
MDMA ("Ecstasy") abuse and high-risk sexual behaviors among 169 gay and bisexual men. Am J Psychiatry (2000) 1.66
Torsades de pointes associated with high dose levomethadyl acetate (ORLAAM). J Addict Dis (2001) 1.65
Enhanced response to repeated d-amphetamine challenge: evidence for behavioral sensitization in humans. Biol Psychiatry (1996) 1.62
Rapid remission of OCD with tramadol hydrochloride. Am J Psychiatry (1999) 1.61
Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med (1992) 1.58
The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder. Biol Psychiatry (1999) 1.58
Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. Br J Psychiatry (2006) 1.58
A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases. Psychopharmacol Bull (1994) 1.58
Autoregulation of the human C/EBP alpha gene by stimulation of upstream stimulatory factor binding. Mol Cell Biol (1995) 1.57
Minimizing and managing antidepressant side effects. J Clin Psychiatry (1995) 1.57
Unipolar mania reconsidered: evidence from an elderly cohort. Br J Psychiatry (1994) 1.57
The pain of being borderline: dysphoric states specific to borderline personality disorder. Harv Rev Psychiatry (1999) 1.56
A portable, easily performed muscle power test and its association with falls by elderly persoms. Arch Phys Med Rehabil (1991) 1.55
Residual catatonic state following neuroleptic malignant syndrome. J Clin Psychopharmacol (2000) 1.55
Olanzapine treatment of female borderline personality disorder patients: a double-blind, placebo-controlled pilot study. J Clin Psychiatry (2001) 1.55
Obsessive compulsive spectrum disorder. J Clin Psychiatry (1994) 1.54
The chemical composition of faeces in uraemia, as revealed by in-vivo faecal dialysis. Clin Sci (1968) 1.53
Glycerol induced hemoglobinuric acute renal failure in the rat. II. The experimental model, predisposing factors, and pathophysiologic features. Nephron (1967) 1.52
Treatment histories of borderline inpatients. Compr Psychiatry (2001) 1.52
Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder. Lancet (1994) 1.52
Predominant recurrence polarity among 928 adult international bipolar I disorder patients. Acta Psychiatr Scand (2011) 1.52
Is childhood sexual abuse a risk factor for bulimia nervosa? Am J Psychiatry (1992) 1.51
Open study of the catechol-O-methyltransferase inhibitor tolcapone in major depressive disorder. J Clin Psychopharmacol (1999) 1.50
Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. Am J Psychiatry (1986) 1.47
Prevalence and severity of akathisia in patients on clozapine. Biol Psychiatry (1991) 1.47
Mania, psychosis, and antipsychotics. J Clin Psychiatry (1996) 1.47
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design. Schizophr Res (2003) 1.47
Participation of the transcription factor C/EBP delta in the acute-phase regulation of the human gene for complement component C3. Proc Natl Acad Sci U S A (1993) 1.46
Anxiety disorders in major depression. Compr Psychiatry (2000) 1.46
Demonstration of Epstein-Barr virus in primary central nervous system lymphomas by the polymerase chain reaction and in situ hybridization. Hum Pathol (1990) 1.45
The adverse effect profile and efficacy of divalproex sodium compared with valproic acid: a pharmacoepidemiology study. J Clin Psychiatry (1999) 1.45
Substance abuse and the chronically mentally ill: a description of dual diagnosis treatment services in a psychiatric hospital. Community Ment Health J (1995) 1.45
Serum concentrations of clozapine and its major metabolites: effects of cotreatment with fluoxetine or valproate. Am J Psychiatry (1994) 1.45
Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics (2000) 1.45
Sites of ammonia addition to tubular fluid in rats with chronic metabolic acidosis. Kidney Int (1981) 1.45
First-episode schizophreniform disorder: comparisons with first-episode schizophrenia. Schizophr Res (2000) 1.44
An overview of the treatment of schizoaffective disorder. J Clin Psychiatry (1999) 1.44
Valproate in the treatment of rapid-cycling bipolar disorder. J Clin Psychopharmacol (1988) 1.44
The 10-year course of psychosocial functioning among patients with borderline personality disorder and axis II comparison subjects. Acta Psychiatr Scand (2010) 1.44
Increasing frequency of the diagnosis of obsessive-compulsive disorder. Am J Psychiatry (1992) 1.43
Cognitive features of borderline personality disorder. Am J Psychiatry (1990) 1.43
Are impulse-control disorders related to bipolar disorder? Compr Psychiatry (1996) 1.42
Patellofemoral joint kinematics in individuals with and without patellofemoral pain syndrome. J Bone Joint Surg Am (2006) 1.42
Canadian and American psychiatrists' attitudes toward dissociative disorders diagnoses. Can J Psychiatry (2001) 1.42
Renal artery surgery in patients with presumptive renovascular hypertension. Can Med Assoc J (1967) 1.41
First-episode schizophrenic psychosis differs from first-episode affective psychosis and controls in P300 amplitude over left temporal lobe. Arch Gen Psychiatry (1998) 1.40
Shifts in diagnostic frequencies of schizophrenia and major affective disorders at six North American psychiatric hospitals, 1972-1988. Am J Psychiatry (1993) 1.40
Folate, vitamin B12, and homocysteine in major depressive disorder. Am J Psychiatry (1997) 1.35
Axis II comorbidity of borderline personality disorder. Compr Psychiatry (1998) 1.34
Uniparental disomy for chromosome 16 in humans. Am J Hum Genet (1993) 1.33
Timing of onset of antidepressant response with fluoxetine treatment. Am J Psychiatry (2000) 1.30
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample. Schizophr Res (2003) 1.29
Discriminating borderline personality disorder from other axis II disorders. Am J Psychiatry (1990) 1.29
Major depressive subtypes and treatment response. Biol Psychiatry (1997) 1.28
MRI study of cavum septi pellucidi in schizophrenia, affective disorder, and schizotypal personality disorder. Am J Psychiatry (1998) 1.28
Biodistribution of an adenoviral vector carrying the luciferase reporter gene following intravesical or intravenous administration to a mouse. Cancer Gene Ther (1999) 1.28
The 10-year course of physically self-destructive acts reported by borderline patients and axis II comparison subjects. Acta Psychiatr Scand (2008) 1.27
Muscle dysmorphia in male weightlifters: a case-control study. Am J Psychiatry (2000) 1.27
Composite International Diagnostic Interview screening scales for DSM-IV anxiety and mood disorders. Psychol Med (2012) 1.26
Validation of the prospective NIMH-Life-Chart Method (NIMH-LCM-p) for longitudinal assessment of bipolar illness. Psychol Med (2000) 1.24